Antwerp Declaration

Photo
26.02.2025 • News

European Chemical Industry Becoming Extinct

Ahead of the unveiling of the EU’s Clean Industrial Deal, Ineos Chairman and CEO, Sir Jim Ratcliffe, authored an open letter to emphasize the importance of supportive political decisions and measures for the European industry. Releasing the open letter, Ineos stated: “A year on from the signing of ‘The Antwerp Declaration for a European Industrial Deal’ we have not seen the action necessary to stem the decline of European industry. Ineos has continued to invest in Europe; however, it is now an exception in a landscape of deindustrialization and closures.” Please read the complete open letter below:

Photo
05.06.2024 • NewsStrategy

Trying Times and a Wave of Light

In February, industry leaders from 20 industrial sectors presented the ‘Antwerp Declaration for a European Industrial Deal’. The declaration emphasizes industry's dedication to Europe's transformation and outlines urgent needs to enhance Europe's competitiveness, resilience, and sustainability amid challenging economic circumstances.

Photo
20.02.2024 • News

Industry Leaders Call for Urgent Actions to Boost European Competitiveness

Today, 73 industry leaders from 20 industrial sectors handed over "The Antwerp Declaration for a European Industrial Deal" to Belgian Prime Minister Alexander De Croo and Commission President Ursula von der Leyen. The declaration emphasizes industry's dedication to Europe's transformation and outlines urgent needs to enhance Europe's competitiveness, resilience, and sustainability amid challenging economic circumstances.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.